Osteosarcoma (Osteogenic Sarcoma)

Osteosarcoma is a type of bone cancer that most commonly affects the long bones in the arms and legs, especially around the knee. It usually develops in children, teenagers, and young adults during periods of rapid bone growth. This cancer starts in the cells that form new bone, causing a painful, growing lump or swelling near a joint. It can weaken the bone, increasing the risk of fractures. The disease primarily impacts the skeletal system and can spread to other parts of the body, most often the lungs. Early symptoms include persistent bone pain and swelling, which may worsen at night or with activity. Diagnosis and treatment are critical to managing the disease and improving outcomes.

Osteosarcoma is a highly malignant primary bone tumor characterized by the production of osteoid matrix by malignant mesenchymal cells. It arises most frequently in the metaphyseal regions of long bones during adolescence, coinciding with rapid bone growth. The pathogenesis involves genetic alterations such as mutations in the RB and TP53 tumor suppressor genes, leading to uncontrolled proliferation of osteoblast precursors. Clinically, it presents with localized bone pain, swelling, and sometimes pathological fractures. Radiographically, it shows a mixed lytic and sclerotic lesion with a characteristic Codman triangle and sunburst periosteal reaction. The major clinical significance lies in its aggressive nature and potential for early hematogenous metastasis, primarily to the lungs, necessitating prompt diagnosis and multimodal treatment.